ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management.
暂无分享,去创建一个
B. Spring | C. Thompson | D. Faigel | D. Schillinger | B. Chand | B. Dunkin | O. Hamdy | J. Tice | L. Kaplan | M. Ryou | R. Rothstein | K. Mergener | R. Kushner | Nitin Kumar | K. Mcquaid | S. Edmundowicz | Shelby Sullivan | William Dietz | E. Wilson | B. A. Abu Dayyeh | C. Burke | J. Vargo | Herbert Lerner | C. Apovian | A. Chandraker | T. Deas | O. Ernest | S. Garber | Michael C Larsen | G. Littenberg | C. Mantzoros | S. Mattar | Rachel L. Moore | M. Rinella | K. Woods | N. Zundel
[1] C. Thompson,et al. Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study , 2016, Diabetes Care.
[2] C. Thompson,et al. 1044 Endoscopic Dual-path Enteral Bypass Using a Magnetic Incisionless Anastomosis System (IAS) , 2016 .
[3] O. Hamdy,et al. Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study , 2017, BMJ Open Diabetes Research and Care.
[4] R. Kushner. Weight loss strategies for treatment of obesity. , 2014, Progress in cardiovascular diseases.
[5] D. Schillinger,et al. Hunger and socioeconomic disparities in chronic disease. , 2010, The New England journal of medicine.
[6] E. Ahıshalı. Endoscopic sleeve gastroplasty for obesity: A multicenter study of 248 patients with 24 months follow-up. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[7] D. Azagury,et al. Do Adverse Childhood Experiences Affect Surgical Weight Loss Outcomes? , 2015, Journal of Gastrointestinal Surgery.
[8] J. Samet,et al. Food and Drug Administration , 2007, BMJ : British Medical Journal.
[9] C. Apovian,et al. Pharmacological management of obesity: an endocrine Society clinical practice guideline. , 2015, The Journal of clinical endocrinology and metabolism.
[10] K. Gersin,et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. , 2009, Diabetes technology & therapeutics.
[11] F. Rubino,et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations , 2016, Obesity Surgery.
[12] Kevin D Hall,et al. NIH working group report: Innovative research to improve maintenance of weight loss , 2015, Obesity.
[13] R. Gómez-Huelgas. [Bariatric surgery versus conventional medical therapy for type 2 diabetes]. , 2012, Revista clinica espanola.
[14] Katherine M Flegal,et al. Obesity and socioeconomic status in adults: United States, 2005-2008. , 2010, NCHS data brief.
[15] R. Leibel,et al. To eat or not to eat - how the gut talks to the brain. , 2003, The New England journal of medicine.
[16] J. Greve,et al. The Effect of the Endoscopic Duodenal-Jejunal Bypass Liner on Obesity and Type 2 Diabetes Mellitus, a Multicenter Randomized Controlled Trial , 2014, Annals of surgery.
[17] D. Williamson,et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. , 1998, American journal of preventive medicine.
[18] J Tsevat,et al. Impact of morbid obesity on medical expenditures in adults , 2005, International Journal of Obesity.
[19] W. Garvey,et al. A complications-based clinical staging of obesity to guide treatment modality and intensity , 2013, Current opinion in endocrinology, diabetes, and obesity.
[20] D. Drucker,et al. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes , 2006, The Lancet.
[21] E. Finkelstein,et al. Annual medical spending attributable to obesity: payer-and service-specific estimates. , 2009, Health affairs.
[22] Walter C Willett,et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. , 2003, JAMA.
[23] Asge Asmbs Task Force on Endoscopic Bariatric Therapy. A pathway to endoscopic bariatric therapies. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[24] J. Flier,et al. The Gut and Energy Balance: Visceral Allies in the Obesity Wars , 2005, Science.
[25] G. Formisano,et al. Bariatric Surgery Worldwide , 2017 .
[26] H. Wyatt,et al. Outpatient management of obesity: a primary care perspective. , 2002, Obesity research.
[27] M. Kushel,et al. Food insecurity is associated with chronic disease among low-income NHANES participants. , 2010, The Journal of nutrition.
[28] Barry M. Popkin,et al. Patterns and Trends in Food Portion Sizes , 2013 .
[29] S. Ikramuddin,et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[30] O. Hamdy,et al. The why WAIT program: Improving clinical outcomes through weight management in type 2 diabetes , 2008, Current diabetes reports.
[31] Robert F Kushner,et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.
[32] Joseph P. Glaser,et al. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial , 2016, The American Journal of Gastroenterology.
[33] M. Nauck,et al. Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes , 2006, Diabetologia.
[34] D. Cummings,et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity , 2012, Diabetes Care.
[35] Frank B Hu,et al. Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us. , 2015, Journal of the American College of Cardiology.
[36] C. Thompson,et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. , 2015, Gastrointestinal endoscopy.
[37] Katherine M Flegal,et al. Prevalence of Obesity Among Adults and Youth: United States, 2011-2014. , 2015, NCHS data brief.
[38] Margaret Anderson,et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. , 2008, JAMA.
[39] D. Schillinger,et al. Association of health literacy with diabetes outcomes. , 2002, JAMA.
[40] K. Flegal,et al. Trends in Obesity Among Adults in the United States, 2005 to 2014. , 2016, JAMA.
[41] N. Nguyen,et al. Use and Outcomes of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Gastric Bypass: Analysis of the American College of Surgeons NSQIP. , 2015, Journal of the American College of Surgeons.
[42] U. Ladabaum,et al. Obesity, abdominal obesity, physical activity, and caloric intake in US adults: 1988 to 2010. , 2014, The American journal of medicine.
[43] Claude Bouchard,et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.
[44] N. Scopinaro,et al. Bariatric Surgery Worldwide 2013 , 2015, Obesity Surgery.
[45] M. LeFevre,et al. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. , 2014, Annals of internal medicine.
[46] T. Wadden,et al. Lifestyle Modification for Obesity: New Developments in Diet, Physical Activity, and Behavior Therapy , 2012, Circulation.
[47] C. Thompson,et al. Randomized sham‐controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial , 2017, Obesity.
[48] S. Desmond,et al. Family practice physicians' beliefs, attitudes, and practices regarding obesity. , 1987, American journal of preventive medicine.
[49] L. Genser,et al. Bariatric surgery versus intensive medical therapy for diabetes -5- year outcomes , 2017 .
[50] F. Rubino,et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations , 2016, Diabetes Care.
[51] J. Hebebrand,et al. From monogenic to polygenic obesity: recent advances , 2010, European Child & Adolescent Psychiatry.
[52] J. Griniatsos,et al. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[53] Jennette P. Moreno,et al. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes , 2014, Current Atherosclerosis Reports.
[54] Deepak L. Bhatt,et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. , 2014, The New England journal of medicine.